A new class of cancer drug, which targets the most commonly mutated gene in human cancers, has shown promise in an early-stage trial with 20% response rate in patients with advanced solid cancers. The ...

The protection against cervical cancer provided by human papillomavirus vaccination shows no sign of waning after as much as 18 years, according to a Swedish study of HPV vaccines and cervical cancer ...

An international task force, which includes Australians, has outlined the circumstances in which it may be clinically indicated to take people off certain drugs used to treat mental illness. They say ...